Intocell

Kenya
Lafey, Mandera County, Kenya

Company profile

Intocell company profile

Intocell is a biotechnology company that develops an antibody-drug conjugate platform for the R&D and commercialization of biopharmaceuticals. Intocell creates protein-drug complexes, antibody-drug complexes, and other complexes with their own linkers and drugs.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Country code
KE
Continent
Africa

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Total equity funding
$32.1M
Last funding
Series C / $31.3M / 2021-01-04
Last equity funding
Series C / $31.3M
Investors
10
Lead investors
1
Founders
1
Articles
15
Exited on
2025-05-23

Founders and investors

Founders

Park Tae-gyo

Lead investors

Stonebridge Capital

Investors

Atinum PartnersFriend Investment PartnersSeoul Investment PartnersStonebridge CapitalWinvest Venture Capital